Correlation Between Pmv Pharmaceuticals and Novartis

Can any of the company-specific risk be diversified away by investing in both Pmv Pharmaceuticals and Novartis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pmv Pharmaceuticals and Novartis into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pmv Pharmaceuticals and Novartis AG ADR, you can compare the effects of market volatilities on Pmv Pharmaceuticals and Novartis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pmv Pharmaceuticals with a short position of Novartis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pmv Pharmaceuticals and Novartis.

Diversification Opportunities for Pmv Pharmaceuticals and Novartis

-0.78

Correlation Coefficient

Pmv Pharmaceuticals  Novartis

Pay attention - limited upside

The 3 months correlation between Pmv and Novartis is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Pmv Pharmaceuticals and Novartis AG ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novartis AG ADR and Pmv Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pmv Pharmaceuticals are associated (or correlated) with Novartis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novartis AG ADR has no effect on the direction of Pmv Pharmaceuticals i.e., Pmv Pharmaceuticals and Novartis go up and down completely randomly.

Pair Corralation between Pmv Pharmaceuticals and Novartis

Given the investment horizon of 90 days Pmv Pharmaceuticals is expected to under-perform the Novartis. In addition to that, Pmv Pharmaceuticals is 1.97 times more volatile than Novartis AG ADR. It trades about -0.15 of its total potential returns per unit of risk. Novartis AG ADR is currently generating about 0.22 per unit of volatility. If you would invest  9,395  in Novartis AG ADR on December 28, 2024 and sell it today you would earn a total of  1,797  from holding Novartis AG ADR or generate 19.13% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	98.36%
Values	Daily Returns

Pmv Pharmaceuticals  vs.  Novartis AG ADR

Pmv Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Pmv Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Novartis AG ADR

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Novartis AG ADR are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Novartis unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Pmv Pharmaceuticals and Novartis

The main advantage of trading using opposite Pmv Pharmaceuticals and Novartis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pmv Pharmaceuticals position performs unexpectedly, Novartis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novartis will offset losses from the drop in Novartis' long position.

The idea behind Pmv Pharmaceuticals and Novartis AG ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .